openPR Logo
Press release

Investigation announced for Investors in shares of NanoViricides, Inc. (NYSE: NNVC)

07-24-2020 04:39 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in NanoViricides, Inc. (NYSE: NNVC) shares over potential securities laws violations by NanoViricid

An investigation for investors in NanoViricides, Inc. (NYSE: NNVC) shares over potential securities laws violations by NanoViricid

An investigation was announced over possible securities laws violations by NanoViricides, Inc. in connection with certain financial statements.

Investors who purchased shares of NanoViricides, Inc. (NYSE: NNVC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by NanoViricides, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Shelton, CT based NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.

Shares of NanoViricides, Inc. (NYSE: NNVC) spiked from under $2 per share in mid December 2019 to $17.77 per share on January 27, , respectively to as high as $19.20 per share on January 31, 2020, and declined to as low as $4.60 per share. On March 25, 2020.

On July 23, 2020, NYSE: NNVC shares closed at $6.64 per share.

Those who purchased shares of NanoViricides, Inc. (NYSE: NNVC) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of NanoViricides, Inc. (NYSE: NNVC) here

News-ID: 2095942 • Views: 340

More Releases from Shareholders Foundation

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Investor Alert: Investigation over pot …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Vanda Pharmaceuticals Inc. (NASDAQ: VNDA. Investors who purchased shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) and currently hold any of those Vanda Pharmaceuticals Inc. (NASDAQ: VNDA shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Vanda Pharmaceuticals Inc. (NASDAQ: VNDA
Investigation announced for Long-Term Investors in shares of Milestone Pharmaceu …
Certain directors of Milestone Pharmaceuticals Inc. are under investigation over potential breaches of fiduciary duties. Investors who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) and currently hold any of those NASDAQ: MIST shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Milestone Pharmaceuticals directors breached their fiduciary duties and caused damage to the
Investigation announced for Long-Term Investors in shares of iQIYI, Inc. (NASDAQ …
An investigation was announced for investors in shares of iQIYI, Inc. (NASDAQ: IQ) concerning potential breaches of fiduciary duties by certain directors and officers of iQIYI, Inc.. Investors who are current long term investors in iQIYI, Inc. (NASDAQ: IQ) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: IQ
Investigation announced for Investors in shares of Noble Energy, Inc. (NASDAQ: N …
An investigation was announced concerning whether the takeover of Noble Energy, Inc.is unfair to: NBL stockholders. Investors who purchased shares of Noble Energy, Inc. (NASDAQ: NBL) and currently hold any of those NASDAQ: NBL shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Noble Energy, Inc. breached their fiduciary duties

All 5 Releases